ACE Inhibitor-Induced Cough Onset Timing
Cough from ACE inhibitors can develop anywhere from within hours of the first dose to weeks or months after starting therapy. 1
Timing of Onset
The onset of ACE inhibitor-induced cough has a remarkably wide temporal window:
- Immediate onset: Can occur within hours of the first dose 1
- Delayed onset: May be delayed for weeks to months after initiation of therapy 1
- Most common timeframe: The majority of cases develop within the first 4 weeks of therapy 2
In a Malaysian cohort study, 10.7% of patients developed cough on the very day of therapy initiation, and approximately half of all cases occurred within the first week 3. Another study found that all patients who developed cough did so within 4 weeks of ACE inhibitor initiation 2.
Clinical Characteristics
The cough is typically:
- Dry and nonproductive 1
- Associated with a tickling or scratching sensation in the throat 1
- Often worse at night (79.4% of patients report increased nocturnal intensity) 2
- Not dose-dependent 1, 2
Important Clinical Implications
You must consider ACE inhibitors as a cause of chronic cough regardless of the temporal relationship between starting the medication and cough onset 1. This is a Grade B recommendation from the ACCP guidelines. Even if a patient has been on an ACE inhibitor for months or years without issue, the drug can still be the culprit if they develop a new cough.
Resolution Timeline
When the ACE inhibitor is discontinued:
- Cough typically resolves within 1 to 4 weeks 1
- In a subgroup of patients, resolution may be delayed up to 3 months 1
Risk Factors
Cough occurs more commonly in:
- Women (37.9% vs 15.5% in men) 1, 2
- Nonsmokers 1
- Persons of Chinese origin 1
- Patients with underlying asthma or bronchial hyperreactivity 4
Management Algorithm
If a patient on an ACE inhibitor develops chronic cough: Discontinue the ACE inhibitor regardless of how long they've been on it 1
Confirm the diagnosis: Wait 1-4 weeks (up to 3 months in some cases) to see if cough resolves 1
Switch therapy: Replace with an angiotensin receptor blocker (ARB), which has a cough incidence similar to placebo (Grade A recommendation) 1
Consider rechallenge: In patients with compelling reasons to use an ACE inhibitor, approximately 30% will not develop cough on rechallenge 1
Common Pitfall
Do not assume the ACE inhibitor is innocent just because the patient has been taking it for months or years without problems. The delayed onset can occur at any point during therapy 1, 5.